InvestorsHub Logo

Bourbon_on_my_cornflakes

05/05/17 2:07 PM

#104181 RE: baltimorebullet #104178

dont see any reason why they would have to tell us. Not a p2 test. More like a I would hope any partner is running tests so they can pay up big for a partnership.

stealthways

05/05/17 2:15 PM

#104182 RE: baltimorebullet #104178

Just guessing, but maybe in Greece, Germany, Israel, Aust. or one of the other countries they have operated in, may have different rules for testing drugs? I have long thought that this is likely and the implications, if correct, are large.....

Investor2014

05/05/17 2:35 PM

#104186 RE: baltimorebullet #104178

I fear everyone are over interpreting the example 'embodiments' in the seizure control patent description section. These are not claims, but examples of the kind embodiments that someone skilled in the art would conceive as a possible uses of the invention. It is about disclosing as much as possible to prevent others from navigating and protecting some use of the invention that you'd rather not see happening. Once disclosed, whether ultimately useful or not, no one can patent that method of use.

XenaLives

05/05/17 11:16 PM

#104260 RE: baltimorebullet #104178

It probably wouldn't be the company per se, but one of the associated researchers. International laws vary, but this is all speculation.

An experimental trial by an affiliated researcher would not be a material event.